2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Vivo Opportunity, LLC | 10% Owner | 3,158,851 | Jul 21, 2020 |
| Vivo Opportunity Fund, L.P. | 10% Owner | 3,158,851 | Jul 21, 2020 |
| Vivo Capital IX, LLC | 10% Owner | 3,158,851 | Jul 21, 2020 |
| Vivo Capital Fund IX, L.P. | 10% Owner | 3,158,851 | Jul 21, 2020 |
| Carusi Michael A | 10% Owner | 2,143,681 | Dec 15, 2021 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5, 2026 | Klencke Barbara | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 5, 2026 | Klencke Barbara | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 18, 2026 | Feb 20, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 37.5 | -565 | -0.64% | ✗ | $1.3K |
| Feb 17, 2026 | Feb 19, 2026 | Lettmann Jason | CEO | Sell | 37.5 | -2,201 | -0.71% | ✗ | $5K |
| Feb 2, 2026 | Feb 4, 2026 | GOODMAN COREY S | Director | Buy | 100.0 | +3,184,713 | 60.45% | ✗ | $5M |
| Jan 26, 2026 | Jan 28, 2026 | Shantharam Harish | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2026 | Jan 28, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2026 | Jan 28, 2026 | Lettmann Jason | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | GOODMAN COREY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | Garland J. Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | Sandler Alan B. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | Curran Daniel J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | Takimoto Chris H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | Hemrajani Rekha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 6, 2026 | Jan 7, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 27.5 | -3,925 | -4.26% | ✗ | $4.4K |
| Oct 14, 2025 | Oct 16, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 14, 2025 | Oct 16, 2025 | Lettmann Jason | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 14, 2025 | Oct 16, 2025 | Shantharam Harish | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 17, 2025 | Sep 19, 2025 | Klencke Barbara | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 16, 2025 | Sep 18, 2025 | Lettmann Jason | CEO | Buy | 95.0 | +92,233 | 43.32% | ✗ | $99.4K |
| Aug 18, 2025 | Aug 20, 2025 | Shantharam Harish | CFO | Buy | 95.0 | +75,000 | 100.00% | ✗ | $58.4K |
| Aug 15, 2025 | Aug 19, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 37.5 | -611 | -0.68% | ✗ | $391.3 |
| Aug 15, 2025 | Aug 19, 2025 | Lettmann Jason | CEO | Sell | 27.5 | -2,382 | -1.11% | ✗ | $1.5K |
| Aug 12, 2025 | Aug 13, 2025 | Curran Daniel J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 13, 2025 | Curran Daniel J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 7, 2025 | Jul 8, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 27.5 | -2,011 | -2.26% | ✗ | $905.2 |
| Jun 30, 2025 | Jul 1, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 27.5 | -1,532 | -1.70% | ✗ | $658.8 |
| Apr 11, 2025 | Apr 15, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 11, 2025 | Apr 15, 2025 | Sandler Alan B. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 11, 2025 | Apr 15, 2025 | Shantharam Harish | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 11, 2025 | Apr 15, 2025 | Lettmann Jason | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 14, 2025 | Mar 18, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Neutral | 82.5 | +3,000 | 3.43% | ✗ | - |
| Mar 14, 2025 | Mar 18, 2025 | Lettmann Jason | CEO | Neutral | 90.0 | +42,000 | 24.67% | ✗ | - |
| Feb 19, 2025 | Feb 21, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 37.5 | -550 | -0.63% | ✗ | $632.6 |
| Feb 19, 2025 | Feb 21, 2025 | Pons Jaume | President | Sell | 45.0 | -1,326 | -0.23% | ✗ | $1.5K |
| Feb 19, 2025 | Feb 21, 2025 | Lettmann Jason | CEO | Sell | 27.5 | -2,159 | -1.25% | ✗ | $2.5K |
| Jan 21, 2025 | Jan 23, 2025 | Hemrajani Rekha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2025 | Jan 23, 2025 | Garland J. Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2025 | Jan 23, 2025 | GOODMAN COREY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2025 | Jan 23, 2025 | Takimoto Chris H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Takimoto Chris H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 21, 2025 | Jan 23, 2025 | Klencke Barbara | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Klencke Barbara | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 21, 2025 | Jan 23, 2025 | Shantharam Harish | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Shantharam Harish | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 21, 2025 | Jan 23, 2025 | Pinto Shelly | SVP, FINANCE AND CAO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2025 | Jan 23, 2025 | Sandler Alan B. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2025 | Jan 23, 2025 | Pons Jaume | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2025 | Jan 23, 2025 | Lettmann Jason | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 6, 2025 | Jan 8, 2025 | Pinto Shelly | CFO | Sell | 27.5 | -2,221 | -2.46% | ✗ | $4K |
| Dec 30, 2024 | Jan 2, 2025 | Pinto Shelly | CFO | Sell | 27.5 | -1,426 | -1.56% | ✗ | $2.3K |
| Dec 30, 2024 | Jan 2, 2025 | Pons Jaume | President | Sell | 26.3 | -10,796 | -1.83% | ✗ | $17.1K |
| Dec 2, 2024 | Dec 4, 2024 | Hemrajani Rekha | Director | Buy | 91.3 | +30,000 | 1000.00% | ✗ | $46.4K |
| Dec 2, 2024 | Dec 4, 2024 | Pinto Shelly | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 2, 2024 | Dec 4, 2024 | Lettmann Jason | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 18, 2024 | Nov 19, 2024 | Sandler Alan B. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Aug 16, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 37.5 | -564 | -0.61% | ✗ | $1.5K |
| Aug 14, 2024 | Aug 16, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 45.0 | -1,365 | -0.42% | ✗ | $3.5K |
| Aug 14, 2024 | Aug 16, 2024 | GARCIA PETER S | CFO | Sell | 37.5 | -761 | -0.62% | ✗ | $2K |
| Aug 14, 2024 | Aug 16, 2024 | Pons Jaume | President | Sell | 45.0 | -1,937 | -0.33% | ✗ | $5K |
| Aug 14, 2024 | Aug 16, 2024 | Lettmann Jason | CEO | Sell | 27.5 | -2,191 | -1.28% | ✗ | $5.7K |
| Aug 5, 2024 | Aug 7, 2024 | Sandler Alan B. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 7, 2024 | Sandler Alan B. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 11, 2024 | Jul 15, 2024 | Pons Jaume | President | Sell | 37.5 | -20,000 | -3.26% | ✓ | $158.1K |
| Jul 5, 2024 | Jul 9, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 26.3 | -1,823 | -1.94% | ✗ | $10K |
| Jul 1, 2024 | Jul 3, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | 27.5 | -1,373 | -1.44% | ✗ | $8K |
| Jul 1, 2024 | Jul 3, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 36.3 | -3,273 | -0.99% | ✗ | $19K |
| Jul 1, 2024 | Jul 3, 2024 | Pons Jaume | President | Sell | 22.5 | -10,758 | -1.78% | ✗ | $62.6K |
| Jun 28, 2024 | Jul 2, 2024 | GARCIA PETER S | CFO | Sell | 26.3 | -1,789 | -1.44% | ✗ | $10.8K |
| Jun 13, 2024 | Jun 24, 2024 | GARCIA PETER S | CFO | Buy | 95.0 | +12,000 | 10.87% | ✗ | $102.3K |
| Jun 13, 2024 | Jun 17, 2024 | GARCIA PETER S | CFO | Buy | 95.0 | +12,000 | 10.87% | ✗ | $102.3K |
| Jun 13, 2024 | Jun 14, 2024 | Hemrajani Rekha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | Garland J. Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | GOODMAN COREY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 4, 2024 | Jun 6, 2024 | Pons Jaume | President | Sell | 37.5 | -20,000 | -3.20% | ✓ | $168.7K |
| May 13, 2024 | May 15, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER | Sell | 37.5 | -12,000 | -3.51% | ✓ | $191.3K |
| May 6, 2024 | May 8, 2024 | Pons Jaume | President | Sell | 35.0 | -20,000 | -3.20% | ✓ | $318.3K |
| Apr 16, 2024 | Apr 18, 2024 | Pons Jaume | President | Sell | 26.3 | -50,000 | -7.64% | ✓ | $710.2K |
| Apr 4, 2024 | Apr 5, 2024 | Pons Jaume | President | Sell | 37.5 | -20,000 | -3.08% | ✓ | $223K |
| Mar 14, 2024 | Mar 18, 2024 | Lettmann Jason | CEO | Buy | 83.8 | +4,400 | 2.63% | ✗ | $49.8K |
| Feb 14, 2024 | Feb 16, 2024 | Pinto Shelly | SVP, FINANCE AND CAO | Neutral | 90.0 | +15,000 | 19.09% | ✗ | - |
| Feb 14, 2024 | Feb 16, 2024 | GARCIA PETER S | CFO | Neutral | 90.0 | +25,000 | 29.29% | ✗ | - |
| Feb 14, 2024 | Feb 16, 2024 | Randolph Sophia | CHIEF MEDICAL OFFICER | Neutral | 85.0 | +30,000 | 9.60% | ✗ | - |
| Feb 14, 2024 | Feb 16, 2024 | Pons Jaume | President | Neutral | 82.5 | +30,000 | 4.85% | ✗ | - |
| Feb 14, 2024 | Feb 16, 2024 | Lettmann Jason | CEO | Neutral | 90.0 | +60,000 | 55.96% | ✗ | - |
| Jan 4, 2024 | Jan 5, 2024 | Pinto Shelly | SVP, Finance and CAO | Sell | 26.3 | -2,717 | -3.34% | ✗ | $37K |
| Dec 29, 2023 | Jan 3, 2024 | Pinto Shelly | SVP, Finance and CAO | Sell | 26.3 | -1,631 | -1.97% | ✗ | $24.5K |
| Dec 29, 2023 | Jan 3, 2024 | Randolph Sophia | Chief Medical Officer | Sell | 36.3 | -3,128 | -0.99% | ✗ | $47K |
| Dec 29, 2023 | Jan 3, 2024 | GARCIA PETER S | CFO | Sell | 26.3 | -1,893 | -2.17% | ✗ | $28.5K |
| Dec 29, 2023 | Jan 3, 2024 | Pons Jaume | President | Sell | 22.5 | -7,179 | -1.15% | ✗ | $108K |
| Sep 8, 2023 | Sep 12, 2023 | Lettmann Jason | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 25, 2023 | Jul 27, 2023 | Randolph Sophia | Chief Medical Officer | Neutral | 90.0 | +34,000 | 12.08% | ✗ | - |
| Jul 25, 2023 | Jul 27, 2023 | Pinto Shelly | SVP, Finance and CAO | Neutral | 90.0 | +26,000 | 46.67% | ✗ | - |
| Jul 25, 2023 | Jul 27, 2023 | GARCIA PETER S | CFO | Neutral | 90.0 | +32,000 | 58.46% | ✗ | - |
| Jul 25, 2023 | Jul 27, 2023 | Pons Jaume | CEO | Neutral | 90.0 | +89,000 | 16.59% | ✗ | - |
| Jul 6, 2023 | Jul 7, 2023 | Pinto Shelly | VP, Finance and CAO | Sell | 26.3 | -7,345 | -11.65% | ✗ | $47.9K |
| Jun 30, 2023 | Jul 5, 2023 | Randolph Sophia | Chief Medical Officer | Sell | 36.3 | -1,605 | -0.57% | ✗ | $11.8K |
| Jun 30, 2023 | Jul 5, 2023 | Pons Jaume | CEO | Sell | 36.3 | -3,208 | -0.59% | ✗ | $23.5K |
| Jun 30, 2023 | Jul 5, 2023 | Pinto Shelly | VP, Finance and CAO | Sell | 37.5 | -466 | -0.73% | ✗ | $3.4K |
| Jun 30, 2023 | Jul 5, 2023 | GARCIA PETER S | CFO | Sell | 27.5 | -887 | -1.59% | ✗ | $6.5K |